Reports from the conference.

Introduction

In this issue of HTB, we continue our extended coverage of this important meeting (see previous two issues of HTB for earlier reports.

The reports in this issue covers timing of HAART, treatment access, women’s health and paediatric care and include:

• Immediate HAART reduces death and AIDS progression over 48 weeks in patients with acute OIs

• Utility of routine viral load, CD4 count and clinical monitoring among HIV-positive adults in rural Uganda

• Implementation of more complex regimens for prevention of mother-to-child transmission of HIV in Rwanda

• The estimated cost of switching from d4T to TDF in South Africa

• Gender differences in viral load by CD4 count in men and women

• Immune reconstitution inflammatory syndrome in young children initiating ART

• Complications with BCG vaccination in HIV-positive and negative infants: CHER Study

• The association between clinical characteristics and HIV-infection in very young infants

• Safety and efficacy of boosted darunavir in treatment-experienced children and adolescents at 24 weeks

• Responses to atazanavir-containing HAART in treatment-naïve children in South Africa

• Initial growth, CD4, and viral load responses to HAART in Ugandan compared to UK/Irish HIV-positive children

• Paediatric pharmacokinetic studies

• A pilot study of three treatment strategies for HIV-positive infants

Abstracts for the meeting are online as soon as the conference opens, and many of the most important oral abstract sessions and overview sessions are posted as webcasts within a day or so. We encourage readers to go directly to the source for many of these sessions.

http://www.retroconference.org